Demand For Cheaper Covid-19 Tests | Dr A Velumani Of Thyrocare Technologies To Et Now

Demand for Cheaper COVID-19 Tests | Dr A Velumani of Thyrocare Technologies To ET NOW

Post-COVID Trends In Healthcare Business | Thyrocare Technologies To ET NOW

Private labs to test for COVID-19 | Thyrocare to ET NOW

RT-PCR is the most reliable test in the covid diagnosis: Dr A. Velumani, CEO, Thyrocare Technologies

Safety Equipment Shortages? | Dr A Velumani of Thyrocare to ET NOW

Daily COVID Cases Declining - Is India Out Of Woods Yet? | Thyrocare's Dr A Velumani To ET Now

Herd Immunity Versus Vaccine Debate | Dr A Velumani Of Thyrocare To ET NOW

India in the midst of a second COVID-19 wave? | Thyrocare MD Dr A Velumani to ET NOW

Without herd immunity there is no relief from Covid-19: A Velumani, Thyrocare Tech

The Economic Times

Covid segment to be as big a part of revenue as non-Covid segment for laboratories: A Velumani

The Economic Times

Free testing only for those EWS patients with Ayushman ID | A Velumani of Thyrocare speak to ET Now

From Poverty to 3300 crores. How Dr.Velumani built Thyrocare? | Dr Velumani |IBP Episode 3

Thyrocare's A Velumani On Covid-19 Testing In India

Antibody test kits not yet available in India, postponed 4 times, says Thyrocare MD, Dr A. Velumani

Seeing decline in positivity rate | Dr A Velumani, Thyrocare | The Market

Early data proves Indians are better immunised against COVID-19 | Dr Velumani, MD - Thyrocare

New COVID immunity test. How does it work? - Faye D'Souza | Dr A Velumani

Thyrocare Technologies Q4 Earnings Performance

Dr. A. Velumani, tells ET Now about the impact of demonetisation on Diagnostic Industry

A. Velumani of Thyrocare Tech speaks on aggressive PE funding slowing down